RAVELCARE LIMITED IPO
RAVELCARE LIMITED was a SME IPO, offered at ₹123–₹130 per share. The issue was subscribed 406.72× overall (QIBs 155.91×, NIIs 554.93×, retail 463.13×). It listed on 8 Dec 2025 at ₹201 and closed its first day at ₹191, a listing gain of +46.9% versus the ₹130 issue price. It now trades around ₹93 (-28.5% versus the issue price).
Frequently asked questions
- How many times was the RAVELCARE LIMITED IPO subscribed?
- The RAVELCARE LIMITED IPO was subscribed 406.72× overall — 155.91× in the QIB category, 554.93× among non-institutional investors, 463.13× in retail.
- What were the RAVELCARE LIMITED IPO listing gains?
- RAVELCARE LIMITED listed on 8 Dec 2025 at ₹201, closing its first day at ₹191 — a listing gain of +46.9% versus the ₹130 issue price.
- What were the retail allotment odds for the RAVELCARE LIMITED IPO?
- Retail was subscribed 463.13×, so a single-lot application had roughly a 0.2% chance of allotment (about 1 in 463), and allotment was finalised on 4 Dec 2025.
- What was the price band and lot size of the RAVELCARE LIMITED IPO?
- The price band was ₹123–₹130 per share.